ArticleACS medicinal chemistry letters2021

Utilization of Metabolite Identification and Structural Data to Guide Design of Low-Dose IDO1 Inhibitors.

Brett Hopkins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.